Company Directory - Bausch Health Companies Inc.
CCI Score
CCI Score: Bausch Health Companies Inc.
15.65
Latest Event
Bausch Health Lobbying Activity and Political Influence
Review of Bausch Health Companies Inc.'s lobbying activities as reported by OpenSecrets. The profile highlights the firm's engagement in lobbying efforts which, while standard in corporate practices, raises questions about its influence on policy and potential alignment with authoritarian tendencies.
Take Action
So what can you do? Support Bausch Health by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
SABOTEUR
Bausch Health Companies Inc. is currently rated as a Saboteur.
Latest Events
- FEB192025
Review of Bausch Health Companies Inc.'s lobbying activities as reported by OpenSecrets. The profile highlights the firm's engagement in lobbying efforts which, while standard in corporate practices, raises questions about its influence on policy and potential alignment with authoritarian tendencies.
-10
Political Contributions and Lobbying Efforts
March 26
Bausch Health's presence on the OpenSecrets lobbying profile evidences its active political lobbying. While engagement in lobbying is a routine business practice, the influence exerted can contribute to undermining democratic processes. Given the concerns over corporate political influence and alignment with policies that may benefit authoritarian agendas, a moderate negative score is assigned.
- FEB192025
OpenSecrets data reveals Bausch Health’s considerable campaign contributions and lobbying spending in the 2024 cycle, including evidence of revolving door practices among lobbyists. These activities raise concerns about the company’s influence on policy and the promotion of authoritarian agendas.
-30
Executive Political Engagement
March 26
The data indicates that several Bausch Health lobbyists have previously held government positions, exemplifying revolving door practices. This blurring of lines between public service and corporate interests undermines democratic accountability and contributes to authoritarian influence.
-40
Political Contributions and Lobbying Efforts
March 26
Bausch Health spent $750,000 on lobbying in 2024 and made notable campaign contributions. This financial influence, especially when paired with lobbying practices, suggests an effort to sway policy outcomes in favor of corporate interests, aligning with authoritarian tendencies.
- JAN012025
Bausch + Lomb, part of Bausch Health Companies Inc., released a comprehensive Global Human Rights Policy in January 2025. The policy reaffirms the company's strong commitment to upholding international labor rights and human rights standards, including prohibition of forced labor, anti-discrimination measures, and ethical recruitment practices. This proactive stance is designed to safeguard workers' rights and ensure responsible business practices across its global operations and supply chain.
+80
Labor Relations and Human Rights Practices
March 26
The policy demonstrates a strong commitment to labor rights and ethical human rights practices by adhering to international standards and ensuring fair treatment of workers. It explicitly prohibits child labor, forced labor, and discrimination, and it mandates safe working conditions along with the right to collective bargaining. This approach aligns well with anti-fascist and progressive values that prioritize worker rights and equality.
- SEP012024
Bausch Health Companies Inc. released a comprehensive Global Human Rights Policy effective September 1, 2024, outlining strong measures against human trafficking, promoting fair labor practices, non-discrimination, and enforcing ethical supply chain standards.
- JAN012024
Bausch Health Companies Inc. was reported to have spent $590,000 on lobbying in 2024, a move that, from an anti‐fascist perspective, signals an effort to influence political processes in a way that may support undemocratic practices and enhance corporate power.
-40
Political Contributions and Lobbying Efforts
March 26
The reported expenditure of $590,000 on lobbying in 2024 by Bausch Health indicates a significant investment in shaping political policy. This type of activity is often viewed as a method of exerting corporate influence over democratic processes, potentially facilitating policies that favor authoritarian outcomes. From an anti-fascist, left-leaning perspective, such active lobbying is concerning as it may indirectly support undemocratic practices and undermine fair political representation.
Alternatives

Japan
26.16

Corporation
0.49

Belgium (Ghent), Belgium
79.03
Raleigh, USA
56.52
New York, United States
30.41

Bagsværd, Denmark
16.06

Darmstadt, Germany
12.29

Kenilworth, United States
2.89
Copenhagen, Denmark
2.36

Paris, France
0.42
Industries
- 325412
- Pharmaceutical Preparation Manufacturing
- 446110
- Pharmacies and Drug Stores
- 541711
- Research and Development in Biotechnology